Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - PA: IMHA New investigators - Bridge Funding

Université Laval

$100,000.00

Characterizing the role of immune cells' bioenergetics in the pathophysiology of inflammatory arthritis

EF 2013-14

Résumé
More than one million Canadians are affected with inflammatory types of arthritis such as rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus. Among all causes of disability, arthritis ranks first among women and second among men, costing the Canadian economy more than $30 billions annually. Current therapies are expensive and do not completely eliminate the inflammation or provide a cure, often requiring the usage of multiple treatments concurrently. The underlying causes of inflammatory arthritis are not completely understood, but it is well established that the progressive joint destruction that occurs during disease progression results from inappropriate activation of cells of the immune system. Immune cells require energy for housekeeping functions as well as for specific immune functions, and alterations in bioenergetics are often associated with diseases such as diabetes and cancer. Energy metabolism of immune cells is increased in patients with rheumatic diseases, suggesting that the assessment of their bioenergetics could be suitable for monitoring disease activity. This present research study will aim to characterize the bioenergetics and intracellular signaling events occurring in the different immune cell types involved in the pathophysiology of inflammatory arthritis and determine whether therapies can modulate the energy metabolism of these cells. This research will inform us about the diseases and their treatments, leading to new biomarkers and perhaps pave the way for new treatments of inflammatory disorders.
Programme
Operating Grant - PA: IMHA New investigators - Bridge Funding
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
300162
Name
Pelletier Martin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Characterizing the role of immune cells' bioenergetics in the pathophysiology of inflammatory arthritis
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: IMHA New investigators - Bridge Funding
Keyworddelim
Arthritis; Autoimmunity; Cytokine; Energy Metabolism; Inflammation; Rheumatic Diseases
Abstract
More than one million Canadians are affected with inflammatory types of arthritis such as rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus. Among all causes of disability, arthritis ranks first among women and second among men, costing the Canadian economy more than $30 billions annually. Current therapies are expensive and do not completely eliminate the inflammation or provide a cure, often requiring the usage of multiple treatments concurrently. The underlying causes of inflammatory arthritis are not completely understood, but it is well established that the progressive joint destruction that occurs during disease progression results from inappropriate activation of cells of the immune system. Immune cells require energy for housekeeping functions as well as for specific immune functions, and alterations in bioenergetics are often associated with diseases such as diabetes and cancer. Energy metabolism of immune cells is increased in patients with rheumatic diseases, suggesting that the assessment of their bioenergetics could be suitable for monitoring disease activity. This present research study will aim to characterize the bioenergetics and intracellular signaling events occurring in the different immune cell types involved in the pathophysiology of inflammatory arthritis and determine whether therapies can modulate the energy metabolism of these cells. This research will inform us about the diseases and their treatments, leading to new biomarkers and perhaps pave the way for new treatments of inflammatory disorders.
Competitiondate
201309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pelletier, Martin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~